← Open Payments lookup

MICHAEL VINCEN-BROWN: Open Payments

NPI 1003326398 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$90 in 5 payments from 4 companies in 2025. Trend: 2023 $191 · 2024 $55 · 2025 $90

Food & beverage: $90
CompanyPaymentsAmount
Novo Nordisk Inc2$34
Xeris Pharmaceuticals, Inc.1$25
GlaxoSmithKline, LLC.1$18
AstraZeneca Pharmaceuticals LP1$14

Products named: RECORLEV, Ozempic, SHINGRIX, FARXIGA.

Industry payments across ID — which companies pay providers there.